Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2003
11/06/2003US20030206188 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030206187 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003CA2827114A1 Multi plasmid system for the production of influenza virus
11/06/2003CA2484341A1 Novel 35 kd protein
11/06/2003CA2483819A1 Non-immunosuppressive imunogenic or vaccine composition comprising a mutated e7 protein of the hpv-16 virus
11/06/2003CA2483701A1 Constitutively active histamine h3 receptor mutants and uses thereof
11/06/2003CA2483564A1 Chimeric camp factors for vaccination against streptococcus infection
11/06/2003CA2483518A1 Polypeptide having an activity to support proliferation or survival of hematopoietic stem cell or hematopoietic progenitor cell, and dna coding for the same
11/06/2003CA2483513A1 Reporter-selectable hepatitis c virus replicon
11/06/2003CA2483498A1 Generation of plants with improved pathogen resistance
11/06/2003CA2483494A1 Semisynthetic protein-based site-directed probes for identification and inhibition of active sites, and methods therefor
11/06/2003CA2483485A1 Height-related gene
11/06/2003CA2483468A1 Mutated hpv-16 e7 polypeptide, pharmaceutical composition comprising it and its preparation process
11/06/2003CA2483453A1 Combination vaccines including immunogenic gapc and camp factor polypeptides
11/06/2003CA2483441A1 Mannose binding lectin and uses thereof
11/06/2003CA2483433A1 Isolated human proteins that show high homology to human disease proteins, nucleic acid molecules encoding these human proteins, and uses thereof
11/06/2003CA2483431A1 Alternatively spliced nucleic acid molecules
11/06/2003CA2483337A1 Expression of polypeptides in chloroplasts, and compositions and methods for expressing same
11/06/2003CA2483323A1 Contraceptive targets
11/06/2003CA2483106A1 Decoys for treating and/or preventing th2 cytokine-related allergic diseases, gata3 mutant proteins and, pharmaceutical compositions comprising the decoys and the proteins
11/06/2003CA2483007A1 A dna enzyme to inhibit plasminogen activator inhibitor-1
11/06/2003CA2482946A1 Multi plasmid system for the production of influenza virus
11/06/2003CA2482930A1 Epha2 antigen t epitopes
11/06/2003CA2480845A1 Adipocyte complement related protein zacrp8
11/06/2003CA2480291A1 Adipocyte complement related protein zacrp14
11/06/2003CA2385110A1 Co-expression system for large functional proteins
11/05/2003EP1359223A2 Recombinant AAV preparation substantially free of wt aav virus
11/05/2003EP1359222A2 Hybrid human/porcine factor VIII
11/05/2003EP1359221A2 HIV antisense proteins
11/05/2003EP1359220A2 Transgenic plants expressing a cytokine and an autoantigen
11/05/2003EP1359160A1 Androgen receptor overexpressing skeletal myoblasts
11/05/2003EP1359159A2 Analogues of GLP-1
11/05/2003EP1359158A2 Trp-p8 splice variants and regulatory RNA
11/05/2003EP1359157A1 Metallo-proteinase inhibitory agent
11/05/2003EP1359156A2 Papilloma virus vaccine
11/05/2003EP1359155A1 Refolding of membrane proteins using two different detergents
11/05/2003EP1358874A1 Peptide/lipid complex formation by co-lyopholization
11/05/2003EP1358356A1 Dna markers for meat tenderness
11/05/2003EP1358351A2 Diagnosis of known genetic parameters within the mhc
11/05/2003EP1358347A2 Genes expressed in foam cell differentiation
11/05/2003EP1358341A2 Methods for generating resistance against cgmmv in plants
11/05/2003EP1358340A1 Control of bacterial infection by quenching quorum-sensing of plant pathogenic bacteria
11/05/2003EP1358335A2 Nucleotide sequence mediating male fertility and method of using same
11/05/2003EP1358333A2 Genes encoding polypeptides from methylomonas sp. involved exopolysaccharide production
11/05/2003EP1358332A2 A serpin in bifidobacteria
11/05/2003EP1358331A2 Clostridium difficile vaccine
11/05/2003EP1358330A2 Transporters and ion channels
11/05/2003EP1358329A2 Lipid-associated molecules
11/05/2003EP1358328A2 Regulation of human serotonin-like g protein-coupled recepter
11/05/2003EP1358327A2 Proteins and nucleic acids encoding same
11/05/2003EP1358326A2 Proteins associated with cell growth, differentiation, and death
11/05/2003EP1358325A2 Protein modification and maintenance molecules
11/05/2003EP1358323A2 Regulators of apoptosis
11/05/2003EP1358315A2 Identification of an advanced sleep phase syndrome gene in humans
11/05/2003EP1358213A2 Humanized antibodies that recognize beta amyloid peptide
11/05/2003EP1358212A1 Methods for the synthesis of a modified hemoglobin solution
11/05/2003EP1358210A2 Adhesion molecules
11/05/2003EP1358209A2 Crystallization of igf-1
11/05/2003EP1358208A2 Sequences upstream of the carp gene, vectors containing them and uses thereof
11/05/2003EP1358207A1 Sol-fusin: use of gp64-6his to catalyze membrane fusion
11/05/2003EP1358206A2 Peptide-based compounds
11/05/2003EP1358196A2 Human hyperpolarization-activated cyclic nucleotide-gated cation channel hcn3
11/05/2003EP1357973A2 Gssp4 polynucleotides and polypeptides and uses thereof
11/05/2003EP1357940A2 Hepatitis b virus treatment
11/05/2003EP1357939A2 Haemophilus influenza basb212 polynucleotides, polypeptides and use thereof
11/05/2003EP1357938A2 Hyperblebbing bacterial strains and use thereof for production of vaccines
11/05/2003EP1357934A1 Modified interleukin-1 receptor antagonist (il-1ra) with reduced immunogenicity
11/05/2003EP1357931A2 Keratinocyte growth factor-2
11/05/2003EP1357930A2 Histidine-rich glycoprotein
11/05/2003EP1357929A2 Modulation of immune response and methods based thereon
11/05/2003EP1357925A2 Compositions containing an active fraction isolated from hedyotis diffusae and methods of use
11/05/2003EP1203012B1 Refolding of membrane proteins using two different detergents
11/05/2003EP0994945B1 Smad-interacting polypeptides and their use
11/05/2003EP0960197A4 GENES FROM 20q13 AMPLICON AND THEIR USES
11/05/2003EP0912194B1 Polynucleotide vaccine formula, particularly for treating bovine respiratory disease
11/05/2003EP0863991B1 Antigenic preparations
11/05/2003EP0814835B1 Method for enhancing immunogenicity, product obtained and pharmaceutical composition
11/05/2003EP0796867B1 Peptide, bronchodilator and blood flow ameliorant
11/05/2003EP0777679B1 Delivery of nucleic acids
11/05/2003EP0713495B1 Methods of enhancing bioactivity of chemokines
11/05/2003EP0656366B1 Iron-lactoferrin combination and process for producing the same
11/05/2003EP0656061B1 Novel glycoforms of soluble complement receptor 1
11/05/2003EP0651801B1 Polypeptides having serotoninergique activity (5ht5a), nucleic acids coding for these polypeptides and uses thereof
11/05/2003EP0601106B2 Morphogen-induced modulation of inflammatory response
11/05/2003EP0550625B1 Bmp-5 derivatives
11/05/2003EP0489837B1 Inhibition of lymphocyte adherence to vascular endothelium utilizing a novel extracellular matrix receptor-ligand interaction
11/05/2003EP0489058B1 Cystic fibrosis gene
11/05/2003CN1454260A Bacterial strains, genes and enzymes for control of bacterial diseases by quenching quorum-sensing signals
11/05/2003CN1454258A Novel cell wall anchor proteins derived from yeast, genes thereof and cell surface expression systems using the same
11/05/2003CN1454257A Production of recombinant blood clotting factors in human cell lines
11/05/2003CN1454256A The high bone mass gene of 11q13.3
11/05/2003CN1454216A Antibodies to CCR5
11/05/2003CN1454215A Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby
11/05/2003CN1454214A Modified peptides with increased potency
11/05/2003CN1454213A Variants of allergenic proteins of the Group2 of dermatophagoides
11/05/2003CN1454097A Polymer-modified synthetic proteins
11/05/2003CN1454083A Selective androgen receptor modulators and methods for their identification design and use
11/05/2003CN1454082A Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions
11/05/2003CN1453293A Solid phase synthesis method of peptide-spacer-lipoid conjugate, synthesized conjugate and targeting liposome containing the conjugate
11/05/2003CN1453292A Chemical modification method of protein in its affinity protecting active region and its product and use
1 ... 1498 1499 1500 1501 1502 1503 1504 1505 1506 1507 1508 1509 1510 1511 1512 1513 1514 1515 1516 1517 1518 ... 2916